Back to Search
Start Over
PTC Therapeutics Announces Positive Results from Long-Term Treatment Studies and Updates on Regulatory Progress for Vatiquinone Friedreich Ataxia Program
- Source :
- Plus Company Updates. October 10, 2024
- Publication Year :
- 2024
-
Abstract
- WARREN, N.J.: PTC Therapeutics, Inc. has issued the following news release: PTC Therapeutics, Inc. (NASDAQ: PTCT) provided today several positive updates on the vatiquinone Friedreich ataxia (FA) program. The pre-specified [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.812445158